A detailed history of New York State Common Retirement Fund transactions in Erasca, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 60,452 shares of ERAS stock, worth $155,966. This represents 0.0% of its overall portfolio holdings.

Number of Shares
60,452
Previous 37,360 61.81%
Holding current value
$155,966
Previous $47,000 178.72%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025

BUY
$1.36 - $2.18 $31,405 - $50,340
23,092 Added 61.81%
60,452 $131,000
Q2 2025

Oct 08, 2025

BUY
$1.06 - $1.63 $11,131 - $17,116
10,501 Added 39.1%
37,360 $47,000
Q2 2025

Aug 13, 2025

BUY
$1.06 - $1.63 $11,131 - $17,116
10,501 Added 39.1%
37,360 $47,000
Q4 2024

Oct 08, 2025

BUY
$2.44 - $3.23 $19,520 - $25,840
8,000 Added 42.42%
26,859 $67,000
Q4 2024

Jan 31, 2025

BUY
$2.44 - $3.23 $19,520 - $25,840
8,000 Added 42.42%
26,859 $67,000
Q3 2024

Oct 08, 2025

SELL
$2.17 - $3.28 $40,147 - $60,683
-18,501 Reduced 49.52%
18,859 $51,000
Q2 2024

Oct 08, 2025

SELL
$1.79 - $2.63 $33,116 - $48,657
-18,501 Reduced 49.52%
18,859 $44,000
Q2 2024

Jul 31, 2024

BUY
$1.79 - $2.63 $791 - $1,162
442 Added 2.4%
18,859 $45,000
Q1 2024

Oct 08, 2025

SELL
$1.67 - $2.55 $31,634 - $48,304
-18,943 Reduced 50.7%
18,417 $37,000
Q1 2024

May 07, 2024

SELL
$1.67 - $2.55 $688 - $1,050
-412 Reduced 2.19%
18,417 $38,000
Q4 2023

Oct 08, 2025

SELL
$1.67 - $2.49 $30,946 - $46,142
-18,531 Reduced 49.6%
18,829 $40,000
Q4 2023

Feb 01, 2024

SELL
$1.67 - $2.49 $300 - $448
-180 Reduced 0.95%
18,829 $40,000
Q3 2023

Oct 08, 2025

SELL
$1.97 - $2.91 $36,151 - $53,401
-18,351 Reduced 49.12%
19,009 $37,000
Q3 2023

Nov 07, 2023

BUY
$1.97 - $2.91 $581 - $858
295 Added 1.58%
19,009 $37,000
Q2 2023

Oct 08, 2025

SELL
$2.57 - $3.3 $47,920 - $61,531
-18,646 Reduced 49.91%
18,714 $51,000
Q1 2023

Oct 08, 2025

SELL
$2.74 - $4.44 $68,500 - $111,000
-25,000 Reduced 57.19%
18,714 $56,000
Q1 2023

May 02, 2023

SELL
$2.74 - $4.44 $68,500 - $111,000
-25,000 Reduced 57.19%
18,714 $56,000
Q4 2022

Oct 08, 2025

BUY
$3.89 - $8.57 $24,717 - $54,453
6,354 Added 17.01%
43,714 $188,000
Q4 2022

Jan 30, 2023

SELL
$3.89 - $8.57 $147 - $325
-38 Reduced 0.09%
43,714 $188,000
Q3 2022

Nov 08, 2022

BUY
$5.82 - $10.68 $83,435 - $153,108
14,336 Added 48.74%
43,752 $341,000
Q2 2022

Aug 04, 2022

SELL
$4.58 - $8.72 $22,790 - $43,390
-4,976 Reduced 14.47%
29,416 $164,000
Q1 2022

May 05, 2022

BUY
$8.6 - $15.48 $188,469 - $339,244
21,915 Added 175.64%
34,392 $296,000
Q4 2021

Feb 02, 2022

BUY
$12.51 - $22.75 $38,493 - $70,001
3,077 Added 32.73%
12,477 $194,000
Q3 2021

Nov 02, 2021

BUY
$17.43 - $24.34 $163,842 - $228,796
9,400 New
9,400 $199,000

Others Institutions Holding ERAS

About Erasca, Inc.


  • Ticker ERAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,147,000
  • Market Cap $315M
  • Description
  • Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...
More about ERAS
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.